Loading clinical trials...
Loading clinical trials...
The investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Add...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rutgers, The State University of New Jersey
NCT02808416 · Brain Cancer, Neoplasm Metastases
NCT03670992 · Renal Cell Carcinoma, Metastases, Neoplasm
NCT00046423 · Neoplasms, Metastases, Neoplasm
NCT00034918 · Breast Neoplasms, Metastases, Neoplasm
NCT01970644 · Neoplasm Metastases
RWJBarnabas Health - Robert Wood Johnson University Hospital
Hamilton, New Jersey
RWJBarnabas Health - Monmouth Medical Center Southern Campus
Lakewood, New Jersey
RWJBarnabas Health - Saint Barnabas Medical Center
Livingston, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions